These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6083097)

  • 1. [Further studies of pharmacological properties of triacetoneamine].
    Chodera A; Frencel I; Mrozikiewicz A; Szpunar K
    Acta Pol Pharm; 1967; 24(6):651-5. PubMed ID: 6083097
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the relationship between chemical structure and central N-cholinolytic action in acetylene amines and their saturated analogues].
    Zatsepln EP
    Farmakol Toksikol; 1968; 31(4):431-4. PubMed ID: 5698133
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
    Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research on the stimulants of the central nervous system among N,N-disubstituted o-methoxybenzylamines and 3-aminocoumarans].
    Roveri P; Ferdenzi A; Salvadorini S
    Boll Chim Farm; 1976 Dec; 114(12):710-3. PubMed ID: 1267975
    [No Abstract]   [Full Text] [Related]  

  • 5. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Some pharmacological properties of 4-chloroanilide of 5-chlorosalicylic acid].
    Kleinrok Z; Jagiello-Wójtowicz E; Kruszewska A
    Gruzlica; 1971 Feb; 39(2):103-9. PubMed ID: 5551346
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on pharmacological effect of pipethanate. I. Effect of pipethanate on central nervous system].
    Kawashima K; Tanaka S; Nakaura S; Nagao S; Kuwamura T
    Eisei Shikenjo Hokoku; 1971; 89():50-3. PubMed ID: 5170093
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on some pharmacodynamic properties of an indole alkaloid: dregamine. Action on the nervous and muscular systems].
    Albert O; Dupont M; Quirin M
    Ann Pharm Fr; 1970 Dec; 28(12):697-706. PubMed ID: 5516405
    [No Abstract]   [Full Text] [Related]  

  • 10. [Toxicological and pharmacological properties of ubiquinone-9 and hexahydroubiquinone-4].
    Shadurskiĭ KS; Il'iuchenok TIu; Samokhvalov GI; Obol'nikova EA; Gololobov AD
    Farmakol Toksikol; 1982; 45(5):97-101. PubMed ID: 7140964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the central and peripheral pharmacological properties of 1-(2 dimethylaminoethyl)-1-phenylidene].
    Buchel L; Levy J
    Therapie; 1968; 23(5):1135-46. PubMed ID: 4387506
    [No Abstract]   [Full Text] [Related]  

  • 12. [Calcium antagonists and the central nervous system].
    Allain H; Bentué-Ferrer D; Saiag B; Belliard S; Thaminy S
    Therapie; 1993; 48 Spec No():697-705. PubMed ID: 8091356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General pharmacology of cis-malonato[4R,5R)-4,5-bis-(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II).
    Kim DK; Ahn JS; Ryu G; Kim KH; Park CW; Kim MS; Chung MH; Shin SG; Suh YH; Kim YS
    Arzneimittelforschung; 1994 Sep; 44(9):1080-8. PubMed ID: 7986249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental research on ethambutol toxicity on the central nervous system of various animals].
    Grifa P; Jotti D; Benatti G
    G Ital Chemioter; 1967; 14(1):65-9. PubMed ID: 4985268
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of hormones on metabolism in the central nervous system].
    Komissarenko VP; Kononenko VIa
    Vestn Akad Med Nauk SSSR; 1980; (7):37-43. PubMed ID: 6106330
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic properties of certain derivatives of phenylethylamine and phenylmethane.
    Patkowski J; Pelczarska A
    Arch Immunol Ther Exp (Warsz); 1967; 15(1):88-96. PubMed ID: 6048231
    [No Abstract]   [Full Text] [Related]  

  • 17. General pharmacological profile and effects of E-4716, a novel histamine receptor blocker, on the central nervous system.
    Fisas MA; Gutiérrez B; Fort M; Dordal A; García C; Farré AJ
    Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):199-210. PubMed ID: 9646282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and action on the central nervous system of 9,10-dihydropyrrolo [3,4-b][1,4]benzoxazepine derivatives.
    Budzisz E; Kostka K; Szadowska A; Pakulska W
    Acta Pol Pharm; 1994; 51(1):45-50. PubMed ID: 7976433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacodynamics of alizapride (author's transl)].
    Laville C; Margarit J
    Sem Hop; 1982 Feb; 58(6):323-31. PubMed ID: 6280297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological activities and side effects of plafibride.
    Gras J; Basi N; Zapatero J; Bermejo P; Gimenez F; Beascoa E; Llenas J; Bargalló MA; Giráldez A; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1808-16. PubMed ID: 6976173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.